Restricted
Journal Article DKFZ-2024-02655

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Disentangling oncogenic amplicons in esophageal adenocarcinoma.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2024
Nature Publishing Group UK [London]

Nature Communications 15(1), 4074 () [10.1038/s41467-024-47619-4]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Esophageal adenocarcinoma is a prominent example of cancer characterized by frequent amplifications in oncogenes. However, the mechanisms leading to amplicons that involve breakage-fusion-bridge cycles and extrachromosomal DNA are poorly understood. Here, we use 710 esophageal adenocarcinoma cases with matched samples and patient-derived organoids to disentangle complex amplicons and their associated mechanisms. Short-read sequencing identifies ERBB2, MYC, MDM2, and HMGA2 as the most frequent oncogenes amplified in extrachromosomal DNAs. We resolve complex extrachromosomal DNA and breakage-fusion-bridge cycles amplicons by integrating of de-novo assemblies and DNA methylation in nine long-read sequenced cases. Complex amplicons shared between precancerous biopsy and late-stage tumor, an enrichment of putative enhancer elements and mobile element insertions are potential drivers of complex amplicons' origin. We find that patient-derived organoids recapitulate extrachromosomal DNA observed in the primary tumors and single-cell DNA sequencing capture extrachromosomal DNA-driven clonal dynamics across passages. Prospectively, long-read and single-cell DNA sequencing technologies can lead to better prediction of clonal evolution in esophageal adenocarcinoma.

Keyword(s): Humans (MeSH) ; Esophageal Neoplasms: genetics (MeSH) ; Esophageal Neoplasms: pathology (MeSH) ; Adenocarcinoma: genetics (MeSH) ; Adenocarcinoma: pathology (MeSH) ; Organoids: pathology (MeSH) ; Gene Amplification (MeSH) ; DNA Methylation (MeSH) ; Oncogenes: genetics (MeSH) ; Male (MeSH) ; Sequence Analysis, DNA: methods (MeSH) ; Clonal Evolution: genetics (MeSH) ; Female (MeSH)

Classification:

Contributing Institute(s):
  1. NWG Tumorgenese und molekulare Krebsprävention (C150)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Agriculture, Biology and Environmental Sciences ; Current Contents - Life Sciences ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 15 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record
Click to display QR Code for this record

The record appears in these collections:
Relevant for Publication database
User submitted records

 Record created 2024-12-12, last modified 2024-12-12


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)